🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 344174107
- IPO
- 10/23/2020 · $16.00/share
Business: Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention.
Company Contact
- CEO
- Adrian Gottschalk
- CFO
- Allan Reine
- Headquarters
- 500 Technology Square, Suite 700, Cambridge, MA, 02139
- Phone
- 617-586-3100
- Investor Relations
- Allan Reine · 617-586-3100 · areine@foghorntx.com